Evaluation of Angiotensin Converting Enzyme (ACE)-Like Activity of Acellular Hemoglobin

REFERENCES

• Winslow, R.M. (1994). Vasoconstriction and the efficacy of hemoglobin-based blood substitutes. Transf. Clin. Biol. 1(1): 9–14.
   PubMedGoogle Scholar
• Kim, H.W., Greenburg, A.G. (1995). Hemoglobin mediated vasoactivity in isolated vascular rings. Art. Cells, Blood Substitutes, Immobilization Biotechnol. 23(3): 303–309.
   PubMed Web of Science ®Google Scholar
• Kim, H.W., Greenburg, A.G. (1997). Ferrous hemoglobin scavenging of endothelium derived nitric oxide is a principle mechanism for hemoglobin mediated vasoactivities in isolated thoracic aorta. Art. Cells, Blood Substitutes, Immobilization Biotechnol. 25(1–2): 121–133.
   PubMed Web of Science ®Google Scholar
• Kasper, S.M., Walter, M., Grune, F., Bischoff, A., Erasmi, H., Buzello, W. (1996). Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth. Analg. 83: 921–927.
   PubMed Web of Science ®Google Scholar
• Schubert, A., O'Hara, J.F., Przybelski, R.J., Tetzlaff, J.E., Marks, K.E., Mascha, E., Novick, A.C. (2002). Effect of diaspirin (DCLHb HemAssistTM) during high blood loss surgery on selected indices of organ function. Art. Cells, Blood Substitutes, Immobilization Biotechnol. 30(4): 259–283.
   PubMed Web of Science ®Google Scholar
• Alayash, A.I. (2004). Oxygen therapeutics: Can we tame haemoglobin? Nat. Rev. Drug Discov. 3(2): 152–159.
   PubMed Web of Science ®Google Scholar
• Simoni, J. (2005). Endothelial cell response to hemoglobin based oxygen carriers. Is the attenuation of pathological reaction possible?, in Artificial Oxygen Carrier. Its Front Line, K. Kobayashi, E. Tuschida, H. Horinouchi, Eds., Springer-Verlag: Tokyo, pp. 75–126.
   Google Scholar
• Simoni, J., Simoni, G., Martinez-Zaguilan, R., Wesson, D.E., Lox, C.D., Prien, S.D., Kumar, R.V. (1998). Improved blood substitute: Evaluation of its effects on human endothelial cells. ASAIO J. 454(5): M356–M367.
   Google Scholar
• Simoni, J., Simoni, G., Lox, C.D., Prien, S.D., Shires, G.T. (1995). Evidence for the direct inhibition of endothelin-1 secretion by hemoglobin in human endothelial cells. ASAIO J. 41(3): M641–M651.
   PubMedGoogle Scholar
• Gulati, A., Sharma, A.C., Singh, G. (1996). Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Crit. Care Med. 24(1): 137–147.
   PubMedGoogle Scholar
• Tai, J., Kim, H.W., Greenburg, A.G. (1997). Endothelin-1 is not involved in hemoglobin associated vasoactivities. Art. Cells, Blood Substitutes, Immobilization Biotechnol. 25(1–2): 135–140.
   PubMed Web of Science ®Google Scholar
• Wickman, G., Lan, C., Vollrath, B. (2003). Functional roles of the rho/rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemoglobin: relevance to subarachnoid hemorrhage and vasospasm. Circ. Res. 92(7): 809–816.
   PubMedGoogle Scholar
• Cheung, A.T., Driessen, B., Jahr, J.S., Duong, P.L., Ramanujam, S., Chen, P.C., Gunther, R.A. (2004). Blood substitute resuscitation as a treatment modality for moderate hypovolemia. Art. Cells, Blood Substitutes, Immobilization Biotechnol. 32(2): 189–207.
   PubMed Web of Science ®Google Scholar
• Peach, M.J. (1977). Renin-Angiotensin system: Biochemistry and mechanism of action. Physiol. Rev. 57(2): 313–370.
   PubMed Web of Science ®Google Scholar
• Nishi, K., Ueda, S., Sato, D., Nishi, K. (1994). Effects of pyridoxylated hemoglobin polyoxyethylene conjugate and stroma-free hemoglobin on renal vascular responsiveness to vasoactive substances in isolated perfused rat kidney. Artif. Organs. 18(6): 429–438.
   PubMedGoogle Scholar
• Kida, Y., Iwata, S., Gyoutoku, Y., Aikou, A., Yamakawa, T., Nishi, K. (1991). Vascular responsiveness to various vasoactive substances after exchange transfusion with pyridoxalated hemoglobin polyoxyethylene conjugate (PHP) solution in anesthetized rats. Artif. Organs. 15(1): 5–14.
   PubMedGoogle Scholar
• Rioux, F., Drapeau, G., Marceau, F. (1995). Recombinant human hemoglobin (rHb1.1) selectively inhibits vasorelaxation elicited by nitric oxide donors in rabbit isolated aortic rings. J. Cardiovasc. Pharmacol. 25(4): 587–594.
   PubMedGoogle Scholar
• Moisan, S., Drapeau, G., Burhop, K.E., Rioux, F. (1998). Mechanism of the acute pressor effect and bradycardia elicited by diaspirin crosslinked hemoglobin in anesthetized rats. Can. J. Physiol. Pharmacol. 76(4): 434–442.
   PubMedGoogle Scholar
• Usui, M., Egashira, K., Kitamato, S., Koyanagi, M., Katoh, M., Kataoka, C., Shimokawa, H., Takeshita, A. (1999). Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats. Hypertension 34(4 Pt 1): 546–551.
   PubMedGoogle Scholar
• Simoni, J., Simoni, G., Griswold, J.A., Moeller, J.F., Tsikouris, Khanna, A., Roongsritong, C., Wesson, D.E. (2005). Free hemoglobin (Hb)-mediated synthesis of 8-iso prostaglandin F2 alpha and its effects on coronary artery endothelium in chronic renal failure (CRF). ASAIO J. 51(2): 62A ( Abstract).
   Google Scholar
• Badr, K.F., Abi-Antoun, T.E. (2005). Isoprostanes and the kidney. Antiox. Redox Signal. 7(1–2): 236–243.
   PubMedGoogle Scholar
• Baines, A.D., Christoff, B., Wicks, D., Wiffen, D., Pliura, D. (1995). Cross-linked hemoglobin increases fractional reabsorption and GFR in hypoxic isolated perfused rat kidneys. Am. J. Physiol. 269(5 Pt 2): F628–F636.
   PubMedGoogle Scholar
• Burchop, K., Gordon, D., Estep, T. (2004). Review of hemoglobin-induced myocardial lesion. Art. Cells, Blood Substitutes, Immobilization Biotechnol. 32(3): 353–374.
   PubMedGoogle Scholar
• Struthers, A.D., MacDonald, T.M. (2004). Review of aldosterone- and angiotensin II-induced target organ damage and prevention. Cardiovasc. Res. 61(4): 663–670.
   PubMedGoogle Scholar
• Stier, C.T., Chander, P.N., Rocha, R. (2002). Aldosterone as a mediator in cardiovascular injury. Cardiol. Rev. 10(2): 97–107.
   PubMedGoogle Scholar
• Campbell, D.J., Kladis, A. (1990). Simultaneous radioimmunoassay of six angiotensin peptides in arterial and venous plasma of man. J. Hypertens. 8(2): 165–172.
   PubMedGoogle Scholar
• Halliwell, B., Clement, M.V., Long, L.H. (2000). Hydrogen peroxide in the human body. FEBS Lett. 466(1): 10–13.
   Google Scholar
• Simoni, J., Simoni, G., Lox, C.D., Feola, M. (1994). Reaction of human endothelial cells to bovine hemoglobin solutions and tumor necrosis factor. Art. Cells, Blood Substitutes, Immobilization Biotechnol. 22(3): 777–787.
   PubMed Web of Science ®Google Scholar
• Simoni, J., Simoni, G., Lox, C.D., Prien, S.D., Shires, G.T. (1997). Modified hemoglobin solution, with desired pharmacological properties does not activate nuclear transcriptional factor NF-kappa B in human vascular endothelial cells. Art. Cells, Blood Substitutes, Immobilization Biotechnol. 25(1–2): 193–210.
   PubMed Web of Science ®Google Scholar
• Simoni, J., Feola, M., Canizaro, P.C. (1990). Generation of free oxygen radicals and the toxicity of hemoglobin solutions. Biomat. Art. Cells, Art. Org. 18(2): 189–202.
   PubMed Web of Science ®Google Scholar
• Simoni, J., Simoni, G., Feola, M. (1993). Chromatographic analysis of biopolymers distribution in poly-hemoglobin, and intermolecularly crosslinked hemoglobin solution. Analyt. Chim. Acta. 279: 73–88.
   Google Scholar
• Simoni, J., Simoni, G., Wesson, D.E., Griswold, J.A., Feola, M. (2000). A novel hemoglobin-adenosine-glutathione based blood substitute: Evaluation of its effects on human blood ex vivo. ASAIO J. 46: 679–692.
   PubMed Web of Science ®Google Scholar
• Perutz, M.F., Fermi, G., Abraham, D.J., Poyart, C., Burseaux, E. (1986). Hemoglobin as a receptor of drugs and peptides: X-ray studies of the stereochemistry of binding. J. Am. Chem. Soc. 108: 1064–1078.
   Web of Science ®Google Scholar
• Simoni, J., Simoni, G., Feola, M., Canizaro, P.C. (1991). Evaluation of anion-exchange liquid chromatography for purification of hemoglobin from peptides and other proteins. Analyt. Chim. Acta. 249: 169–183.
   Web of Science ®Google Scholar
• Suvorava, T., Lauer, N., Kumpf, S., Jacob, R., Meyer, W., Kojda, G. (2005). Endogenous vascular hydrogen peroxide regulates arteriolar tension in vivo. Circulation 112: 2487–2495.
   PubMed Web of Science ®Google Scholar
• Simoni, J., Simoni, G., Lox, C.D., McGunegle, D.E., Feola, M. (1994). Cytokines and PAF release from human monocytes and macrophages: Effects of hemoglobin and contaminants. Art. Cells, Blood Substitutes, Immobilization Biotechnol. 22(3): 525–534.
   PubMed Web of Science ®Google Scholar
• Feola, M., Simoni, J., Dobke, M., Canizaro, P.C. (1988). Complement activation and the toxicity of stroma-free hemoglobin solutions in primates. Circulatory Shock 25: 275–290.
   PubMedGoogle Scholar
• Tejedor, C., Lorente, J.A., Delgado, M.A., Fernandez-Segoviano, P., Se Paula, M., Tobalina, R., Alonso, M., Moscoso, A., Soto, F., Blazquez, J., Esteban, A. (2002). Interaction between hemoglobin and glutathione in the regulation of blood flow in normal and septic pigs. Crit. Care Med. 30(11): 2493–2500.
   PubMedGoogle Scholar
• Mandal, R., Teixeira, C., Li, X.F. (2003). Studies of cisplatin and hemoglobin interactions using nanospray mass spectrometry and liquid chromatography with inductively-coupled plasma mass spectrometry. Analyst 128(6): 629–634.
   PubMedGoogle Scholar
• Kaca, W., Roth, R.I., Levin, J. (1994). Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biological activity. J. Biol. Chem. 269(40): 25078–25084.
   PubMed Web of Science ®Google Scholar
• Kim, H.W., Awad, M., Greenburg, A.G. (1994). Coagulation responses of human plasma after hemodilution with hemoglobin solution in vitro. Artif. Cells, Blood Substitutes, Immobilization Biotechnol. 22(3): 613–618.
   PubMed Web of Science ®Google Scholar
• Alayash, A.I. (2001). Oxidative mechanisms of hemoglobin-based blood substitutes. Art. Cells, Blood Substitutes, Immobilization Biotechnol. 29(6): 415–425.
   PubMed Web of Science ®Google Scholar
• Giulivi, C., Davies, K.J. (1990). A novel antioxidant role for hemoglobin. The comproportionation of ferrylhemoglobin with oxyhemoglobin. J. Biol. Chem. 265(32): 19453–19460.
   PubMed Web of Science ®Google Scholar
• Goldman, D.W., Breyer, R.J., Yeh, D., Brockner-Ryan, B.A., Alayash, A.I. (1998). Acellular hemoglobin-mediated oxidative stress toward endothelium: A role for ferryl iron. Am. J. Physiol. 275(3 Pt 2): H1046–H1053.
   PubMedGoogle Scholar
• Akishita, M., Nagai, K., Xi, H., You, W., Sudoh, N., Watanabe, T., Ohara-Imaizumi, M., Nagamatsu, S., Kozaki, K., Horiuchi, M., Toba, K. (2005). Renin-angiotensin system modulates oxidative stress-induced endothelial cell apoptosis in rats. Hypertension 45(6): 1188–1193.
   PubMedGoogle Scholar
• Zilletti, L., Ciuffi, M., Franchi-Micheli, S., Fusi, F., Gentilini, G., Moneti, G., Valoti, M., Sgaragli, G.P. (1994). Cyclooxygenase activity of hemoglobin. Methods Enzymol. 231: 562–573.
   PubMedGoogle Scholar
• Giulivi, C., Cadenas, E. (1998). Oxidation of adrenaline by ferrylmyoglobin. Free Radic. Biol. Med. 25(2): 175–183.
   PubMedGoogle Scholar
• Smani, Y., Faivre, B., Audonnet-Blaise, S., Labrude, P., Vigneron, C. (2005). Relationship between arterial pressure evolution and free hemoglobin distribution into vascular wall in guinea pigs. J. Hypertens. 23(8): A8.
   Google Scholar
• Danser, A.H., Admiraal, P.J., Derkx, F.H., Schalekamp, M.A. (1998). Angiotensin I-to-II conversion in the human renal vascular bed. J. Hypertens. 16(12 Pt 2): 2051–2056.
   PubMedGoogle Scholar
• Li, Q., Feenstra, M., Pfaffendorf, M., Eijsman, L., van Zwieten, P.A. (1997). Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein. J. Cardiovasc. Pharmacol. 29(4): 451–456.
   PubMedGoogle Scholar
• Ardaillou, R. (1997). Active fragments of angiotensin II: Enzymatic pathways of synthesis and biological effects. Curr. Opin. Nephrol. Hypertens. 6(1): 28–34.
   PubMedGoogle Scholar
• Ardaillou, R., Chansel, D. (1996). Angiotensin IV a new component of the renin-angiotensin system, which acts on kidney cells. Bull. Acad. Natl. Med. 180(2): 475–486.
   PubMedGoogle Scholar
• Chappell, M.C., Pirro, N.T., Sykes, A., Ferrario, C.M. (1998). Metabolism of angiotensin-(1–7) by angiotensin-converting enzyme. Hypertension 31(1 Pt 2): 362–367.
   PubMedGoogle Scholar
• Pueyo, M.E., Gonzalez, W., Nicoletti, A., Savoie, F., Arnal, J.-F., Michel, J.-B. (2000). Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappa B activation induced by intracellular oxidative stress. Arterioscler. Thromb. Vasc. Biol. 20: 645–651.
   PubMed Web of Science ®Google Scholar
• Brasier, A.R., Recinos, A., Eledrisi, M.S. (2002). Vascular inflammation and the renin-angiotensin system. Arterioscler. Thromb. Vasc. Biol. 22: 1257–1266.
   PubMed Web of Science ®Google Scholar
• Ridker, P.M., Gauboury, C.L., Conlin, P.R., Seely, E.W., Williams, G.H., Vaughan, D.E. (1993). Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation 87(6): 1969–1973.
   PubMed Web of Science ®Google Scholar
• Rocha, R., Stier, C.T., Kifor, I., Ochoa-Maya, M.R., Rennke, H.G., Williams, G.H., Adler, G.K. (2000). Aldosterone: A mediator of myocardial necrosis and renal arteriopathy. Endocrinology 141(10): 3871–3878.
   PubMedGoogle Scholar
• Reilly, C.F., Tewksbury, D.A., Schechter, N.M., Travis, J. (1982). Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J. Biol. Chem. 257(15): 8619–8622.
   PubMed Web of Science ®Google Scholar
• Wintroub, B.U., Schechter, N.B., Lazarus, G.S., Kaempfer, C.E., Schwartz, L.B. (1984). Angiotensin I conversion by human and rat chymotryptic proteinases. J. Invest. Dermatol. 83(5): 336–339.
   PubMed Web of Science ®Google Scholar
• Tom, B., Garrelds, I.M., Scalbert, E., Stegmann, A.P., Boomsma, F., Saxena, P.R., Danser, A.H. (2003). ACE- versus chymase-dependent angiotensin II generation in human coronary arteries. A matter of efficiency? Arterioscler. Thromb. Vasc. Biol. 23: 251–256.
   PubMed Web of Science ®Google Scholar
• Richard, V., Hurel-Merle, S., Scalbert, E., Ferry, G., Lallemand, F., Bessou, J.P., Thuillez, C. (2001). Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries. Circulation 104(7): 750–752.
   PubMedGoogle Scholar